As of 2026-09-12, the Relative Valuation of Cytosorbents Corp (CTSO) is (193.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.37 USD, the upside of Cytosorbents Corp based on Relative Valuation is -3142.4%.
The range of the Relative Valuation is (194.62) - (198.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.3x - 42.5x | 37.9x |
| Forward P/E multiples | 25.3x - 34.9x | 30.4x |
| Fair Price | (194.62) - (198.14) | (193.80) |
| Upside | -3155.3% - -3210.5% | -3142.4% |
| Date | P/E |
| 2026-09-04 | -0.06 |
| 2026-09-03 | -0.06 |
| 2026-09-02 | -0.07 |
| 2026-09-01 | -0.06 |
| 2026-08-31 | -0.06 |
| 2026-08-28 | -0.06 |
| 2026-08-27 | -0.06 |
| 2026-08-26 | -0.06 |
| 2026-08-25 | -0.06 |
| 2026-08-24 | -0.07 |
| 2026-08-21 | -0.07 |
| 2026-08-20 | -0.05 |
| 2026-08-19 | -0.06 |
| 2026-08-18 | -0.06 |
| 2026-08-17 | -0.07 |
| 2026-08-14 | -0.07 |
| 2026-08-13 | -0.06 |
| 2026-08-12 | -0.07 |
| 2026-08-11 | -0.06 |
| 2026-08-10 | -0.06 |
| 2026-08-07 | -0.06 |
| 2026-08-06 | -0.07 |
| 2026-08-05 | -0.07 |
| 2026-08-04 | -0.07 |
| 2026-08-03 | -0.06 |
| 2026-07-31 | -0.06 |
| 2026-07-30 | -0.06 |
| 2026-07-29 | -0.06 |
| 2026-07-28 | -0.07 |
| 2026-07-27 | -0.06 |
| 2026-07-24 | -0.06 |
| 2026-07-23 | -0.06 |
| 2026-07-22 | -0.07 |
| 2026-07-21 | -0.07 |
| 2026-07-20 | -0.07 |
| 2026-07-17 | -0.06 |
| 2026-07-16 | -0.07 |
| 2026-07-15 | -0.07 |
| 2026-07-14 | -0.07 |
| 2026-07-13 | -0.07 |
| 2026-07-10 | -0.07 |
| 2026-07-09 | -0.07 |
| 2026-07-08 | -0.07 |
| 2026-07-07 | -0.07 |
| 2026-07-06 | -0.08 |
| 2026-07-02 | -0.07 |
| 2026-07-01 | -0.07 |
| 2026-06-30 | -0.07 |
| 2026-06-29 | -0.07 |
| 2026-06-26 | -0.06 |